低级别胶质瘤术后观察:基于2016年WHO分类的长期结局
该研究分析了110例低级别胶质瘤(WHO II级)患者初始手术后采取观察等待策略并在肿瘤进展时再手术的长期结局。中位随访126个月,5年、10年、15年无进展生存率分别为38%、18%、1%,相应恶性转化率分别为17%、39%、71%。分子分型IDHmut/codel是总生存和恶性转化时间的最强预后因素。
要点
- 低级别胶质瘤术后观察等待策略在部分患者中可能合理。
- 分子分型IDHmut/codel是总生存和恶性转化时间的最强预后因素。
- 初始切除程度影响无进展生存、恶性转化时间和总生存。
核心结论
- 初始观察等待后患者病程的最强决定因素是分子肿瘤状态。
- 广泛切除可能延长进展时间和恶性转化时间。
- 观察可能在部分患者中是合理的。
研究设计与样本
- 研究分析了110例低级别胶质瘤(WHO II级)初始手术后采取观察等待策略并在肿瘤进展时再手术的患者。
- 采用Kaplan-Meier法估计无进展生存、恶性转化时间、复发后生存和总生存,采用Log Rank检验和Cox多因素比例风险模型识别预后因素。
主要发现
- 队列包括18例IDH野生型星形细胞瘤、53例IDH突变型星形细胞瘤和39例IDH突变且1p/19q共缺失患者。
- 中位随访126个月(95% CI 109-143)。
- 手术为全切除58例、次全切除28例、活检24例。
- 5年、10年、15年无进展生存率分别为38%、18%、1%,相应恶性转化率分别为17%、39%、71%。
- 初始切除程度影响无进展生存、恶性转化时间和总生存,分子分型IDHmut/codel是总生存和恶性转化时间的最强预后因素。
临床怎么用
- 作者认为,观察可能在部分患者中是合理的。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide detailed long-term data after initial observation for patients after histological confirmation of low grade (WHO II) gliomas according to molecular stratification. METHODS: A series of 110 patients with watchful waiting strategy after initial surgery for LGG and re-surgery at tumor progression were analyzed. Progression-free survival, time to malignant transformation, post-recurrence survival, and overall survival were estimated with the Kaplan-Meier method. Prognostic factors were identified by the Log Rank test and Cox multivariate proportional hazards model. RESULTS: The cohort comprised 18 IDH wild type (IDHwt) and 53 IDH mutated (IDHmut) astrocytomas, and 39 IDH mutated and 1p 19q co-deleted (IDHmut/codel) patients. The median follow-up was 126 (95% CI 109-143) months. Surgery was gross total resection in 58, subtotal resection in 28, and biopsy in 24 patients. Progression-free survival rates at 5, 10 and 15 years was 38% 18% and 1%. The corresponding malignant transformation rates were 17%, 39% and 71%. The initial extent of resection influenced progression-free survival, time to malignant transformation and overall survival. Molecular subtype IDHmut/codel was the strongest prognostic factor for overall survival and for time to malignant transformation. CONCLUSION: The strongest determinant of the patients' course after initial watchful waiting was the molecular tumor status. Extensive resection may increase time to progression and malignant transformation. Observation may be justified in selected patients.
引用
- Jansen E, Hamisch C, Ruess D, et al. Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification. J Neurooncol. 2019. PMID: 31621043. doi:10.1007/s11060-019-03316-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。